James Joel J - OmicsDI

Show results for

Unknown (20)
Genomics (7)
Proteomics (4)
Transcriptomics (2)
Genomic (2)
Metabolomics (1)

Organisms

Homo sapiens (12)

Repository

EGA (7)
PanoramaPublic (3)
biostudies-arrayexpress (2)
dbGaP (2)
MassIVE (1)
MetaboLights (1)

Technology Type

Affymetrix 6.0 (1)
Mass spectrometry (1)

Instrument Platform

Orbitrap Fusion Lumos (1)
GCMS-QP2010 Plus (Shimadzu) (1)

Publication Date

2022 (3)
2012 (2)
2018 (1)
2024 (1)

CHEBI ID

CHEBI:17317 (1)
CHEBI:87978 (1)
CHEBI:32943 (1)
CHEBI:32927 (1)
CHEBI:72688 (1)
CHEBI:46050 (1)
CHEBI:36020 (1)
CHEBI:138264 (1)
CHEBI:4139 (1)
CHEBI:28897 (1)
CHEBI:28817 (1)
CHEBI:78736 (1)
CHEBI:22652 (1)
CHEBI:78679 (1)
CHEBI:15603 (1)
CHEBI:78697 (1)
CHEBI:27823 (1)
CHEBI:16199 (1)
CHEBI:10642 (1)
CHEBI:16977 (1)
CHEBI:17148 (1)
CHEBI:17634 (1)
CHEBI:17295 (1)
CHEBI:12936 (1)
CHEBI:37455 (1)
CHEBI:29864 (1)
CHEBI:15428 (1)
CHEBI:16958 (1)
CHEBI:22660 (1)
CHEBI:17895 (1)

Metabolite Name

D-sorbitol-1-13C m/z_320 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_319 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_206 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_205 (alt. m/z quant.) (1)
D-sorbitol 13C6 m/z_322 (alt. m/z quant.) (1)
Saturated_Guanine manual (1)
Unknown_17.908, 1332, m/z 247 (1)
5-Hydroxyindole-3-acetic acid, 3 TMS, 35.49, 2212 (1)
Unkown_32.762, 2047, m/z 132 (1)
Mannitol, 6 TMS, 30.6, 1915 (alt. m/z quant. high dynamic range) (1)
D-(+)-Glucose, 5 TMS, MEOX, 30.38, 1902 (alt. m/z quant. high dynamic range) (1)
D-(+)-Galactose, 5 TMS, MEOX, 29.94, 1880 (alt. m/z quant. high dynamic range) (1)
Glutamic acid, 3 TMS, 24.79, 1623 (alt. m/z quant. high dynamic range) (1)
Serotonin, x TMS, 39.11, 2470 (alt. m/z quant. high dynamic range) (1)
D-(+)-Turanose, 7 TMS, 42.29, 2702 (1)
L-Lysine, 3 TMS, 26.54, 1712 (1)
L-Leucine, 2 TMS, 16.74, 1274 (1)
L-Leucine, 1 TMS, 13.8, 1155 (1)
Serine, 2 TMS, 16.43, 1260 (1)
Unknown_38.398, 2421, m/z 387 (1)
Benzoic acid, 1 TMS, 16.26, 1254 (1)
Unknown_53.63, 3702, m/z 311 (1)
Unknown_51.603, 3505, m/z283 (1)
Unknown_46.866, 3064, m/z 169 (1)
Unknown_48.018, 3163, m/z 329 (1)
Unknown_46.848, 3063, m/z 169 (1)
Unknown_44.338, 2848, m/z 103 (1)
Unknown_44.010, 2820, m/z 169 (1)
Unknown_44.002, 2820, m/z 131 (1)
Unknown_43.658, 2792, m/z 126 (1)

Study type

Transcription profiling by array (2)

Release Date

2025 (4)
2021 (4)
2018 (3)
2017 (3)
2012 (2)
2020 (2)
2022 (1)
2019 (1)
2015 (1)
2011 (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Evidence of Dynamically Dysregulated Gene Expression Pathways in Hyper-responsive B Cells from African American Lupus Patients

In this report we applied standard and original methods of analysis of gene expression microarray data to delineate differences in the molecular pathways impacted by stimulation of Epstein-Barr virus (EBV) transformed B cells derived from patients with systemic lupus erythematosus (SLE) and normal u...

ORGANISM(S): Homo sapiens

2012-04-25 | E-GEOD-37573 | biostudies-arrayexpress

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

Not available

S-EPMC4669589 | biostudies-literature

Survival, gene and metabolite responses of Litoria verreauxii alpina frogs to fungal disease chytridiomycosis

The fungal skin disease chytridiomycosis has caused the devastating decline and extinction of hundreds of amphibian species globally, yet the potential for evolving resistance, and the underlying pathophysiological mechanisms remain poorly understood. We exposed 406 naïve, captive-raised alpine tree...

2018-01-09 | MTBLS457 | MetaboLights

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.

Not available

S-EPMC5648176 | biostudies-literature

Risk scoring for time to end-stage knee osteoarthritis: data from the Osteoarthritis Initiative.

Not available

S-EPMC7575033 | biostudies-literature

Comparison of radiomic feature aggregation methods for patients with multiple tumors.

Not available

S-EPMC8105371 | biostudies-literature

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

Not available